The SMSNA Foundation supports basic science and clinical research, promotes best practices in clinical care, mentors the next generation of sexual medicine professionals, and provides accurate and reliable patient information regarding the treatment of sexual dysfunction.
The SMSNA Foundation's aims are:
TO ADVANCE RESEARCH
TO MENTOR THE NEXT GENERATION
TO SUPPORT SEXUAL HEALTH INFORMATION
TO DEVELOP DISEASE STATE SPECIFIC AWARENESS
Projects Supported by the SMSNA Foundation
SMSNA/Pfizer Research Fellowship in Men’s Health
Since 2016 the SMSNA Foundation has annually provided a Research Fellowship in Men’s Health, supported by Pfizer. The support is intended to supplement post-doctoral research activities and conference participation to present those activities. The maximum awarded amount is $25,000. For more information click here.
SMSNA Research Fellowship in Andrology, supported by Endo
In 2020 the SMSNA Foundation also granted a Research Fellowship in Andrology, supported by Endo. The support is intended to supplement post-doctoral research activities. The maximum awarded amount is $25,000. For more information click here.
SMSNA Fellowship Training Program in Prosthetic Urology
In 2019 and 2020 the SMSNA Foundation has funded a total of 4 SMSNA Fellowship Training Programs in Prosthetic Urology, supported by Boston Scientific. Each program received $50,000 to be used to directly support salary and employee benefits (e.g., health, dental, vision coverage) for the Fellow. For more information click here.
SMSNA for Patients
SMSNA for Patients, former SexHealthMatters, is an online reference for people seeking help with sexual health issues. The aim of SMSNA for Patients is to help men and their spouses/partners who are living with sexual health issues to understand and navigate the emotional aspects of the condition. It will also help those who haven’t started on a path toward diagnosis and treatment to realize they can improve their condition by seeking medical help, and then assist them in finding the confidence and the words to broach the subject with their healthcare provider. To visit SMSNA for Patients click here.
SMSNA Consensus Statement and White Paper Executive Summary: Adult Onset Hypogonadism
In August 2015, a colloquium of 17 experts commissioned by the SMSNA convened in Washington, DC, to discuss the common clinical scenario of men who present with low testosterone and associated signs and symptoms accompanied by low or normal gonadotropin levels. The primary purpose of this project was to support health care professionals in the development of a deeper understanding of Adult Onset Hypogonadism (AOH), particularly in how it differs from classical primary and secondary hypogonadism, and to provide a conceptual framework to guide its diagnosis, treatment, and follow up. The colloquium was funded through an unrestricted educational grant from Repros Therapeutics, Inc. To read the Consensus Statement and White Paper Executive Summary click here.